<--- Back to Details
First PageDocument Content
Ribbon symbolism / Lung cancer / Breast cancer treatment / Cetuximab / Breast cancer / Prostate cancer / Erlotinib / Non-small-cell lung carcinoma / Ovarian cancer / Medicine / Oncology / Cancer treatments
Date: 2012-07-02 11:14:33
Ribbon symbolism
Lung cancer
Breast cancer treatment
Cetuximab
Breast cancer
Prostate cancer
Erlotinib
Non-small-cell lung carcinoma
Ovarian cancer
Medicine
Oncology
Cancer treatments

Cancer Advances NEWS FROM THE 2003 ASCO ANNUAL MEETING SYMPTOM MANAGEMENT Surgery Provides Relief in Treating Spinal Cord Compression

Add to Reading List

Source URL: www.cancer.net

Download Document from Source Website

File Size: 796,92 KB

Share Document on Facebook

Similar Documents

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

DocID: 1qSc2 - View Document

ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

DocID: 1pJVg - View Document

Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

DocID: 1pH8J - View Document

PAN01 biomarker poster ESMO 15.pdf

PAN01 biomarker poster ESMO 15.pdf

DocID: 1pBTA - View Document

ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c

ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c

DocID: 1p6wp - View Document